– USA, MA – Morphic Therapeutic, a biotechnology company developing a new generation of oral integrin therapies, announced today that it has completed a $80 million Series B financing to fund its two lead programs through clinical proof of concept, and to advance multiple other programs into the clinic.…
– USA, CA – Gossamer Bio, Inc., a new biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products to address high unmet needs of targeted patient populations has announced today its launch by Receptos’ former executive leadership team, Faheem Hasnain and Sheila Gujrathi, M.D.…
– SPAIN, Barcelona – Anaconda Biomed, a pre-clinical stage medical device company focused on the development of the next generation of neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke (AIS), today announces it has closed a Series A financing of 15 million Euro.…
